title: Scintigraphy of benign bone disease.
abstract: Bone scintigraphy is ideally suited for the investigation of benign bone disease as it functions at a physiological level. It is freely available and has whole-body capability and high-contrast resolution. When coupled with single-photon emission computed tomography/computed tomography (SPECT/CT), it can be utilized to provide precise anatomical localization, attenuation correction, and therefore better lesion localization. A considerable volume of data has accumulated on the role of bone scintigraphy in trauma and its complications, overuse injuries, vascular disease of bone, metabolic bone diseases, and a variety of other disorders. This article is an overview of the established applications and signposts of potential future applications with the increasing prevalence of SPECT/CT devices and technical advances in attenuation correction, collimator modeling, and resolution recovery software.
authors.affiliation: Department of Nuclear Medicine, Concord Hospital, Sydney, Australia. hansv@nmrf.org.au
authors.forename: Hans
authors.initials: H
authors.lastname: Van der Wall
authors.forename: Ignac
authors.initials: I
authors.lastname: Fogelman
mesh_terms: D001265:Athletic Injuries / Q000000981:diagnostic imaging; D001847:Bone Diseases / Q000000981:diagnostic imaging*; D001851:Bone Diseases, Metabolic / Q000000981:diagnostic imaging; D002648:Child; D050723:Fractures, Bone / Q000000981:diagnostic imaging; D006801:Humans; D010020:Osteonecrosis / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging